UroGen Pharma
URGN
URGN
79 hedge funds and large institutions have $250M invested in UroGen Pharma in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-7
Holders Change %
-8.14%
% of All Funds
1.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
31
Reduced
30
Closed
11
Calls
$4.89M
Puts
$3.55M
Net Calls
+$1.34M
Net Calls Change
+$1.85M
Top Buyers
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$9.13M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.47M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$4.83M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$2.68M |
| 5 |
HCM
Horton Capital Management
Philadelphia,
Pennsylvania
|
+$2.55M |
Top Sellers
| 1 |
HCM
Highline Capital Management
New York
|
-$11.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.41M |
| 3 |
WCM
Wildcat Capital Management
New York
|
-$4.56M |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$4.32M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.83M |
